D. Yazici Et Al. , "Clinical impact of Glucagon like peptide-1 receptor analogs on the complications of obesity," OBESITY FACTS , vol.16, no.2, pp.149-163, 2023
Yazici, D. Et Al. 2023. Clinical impact of Glucagon like peptide-1 receptor analogs on the complications of obesity. OBESITY FACTS , vol.16, no.2 , 149-163.
Yazici, D., Yapici Eser, H., Kiyici, S., Sancak, S., Sezer, H., Uygur, M., ... Yumuk, V.(2023). Clinical impact of Glucagon like peptide-1 receptor analogs on the complications of obesity. OBESITY FACTS , vol.16, no.2, 149-163.
Yazici, Dilek Et Al. "Clinical impact of Glucagon like peptide-1 receptor analogs on the complications of obesity," OBESITY FACTS , vol.16, no.2, 149-163, 2023
Yazici, Dilek Et Al. "Clinical impact of Glucagon like peptide-1 receptor analogs on the complications of obesity." OBESITY FACTS , vol.16, no.2, pp.149-163, 2023
Yazici, D. Et Al. (2023) . "Clinical impact of Glucagon like peptide-1 receptor analogs on the complications of obesity." OBESITY FACTS , vol.16, no.2, pp.149-163.
@article{article, author={Dilek Yazici Et Al. }, title={Clinical impact of Glucagon like peptide-1 receptor analogs on the complications of obesity}, journal={OBESITY FACTS}, year=2023, pages={149-163} }